Sven Påhlman (Former)
1 – 20 of 105
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Cytoplasmic HIF-2α as tissue biomarker to identify metastatic sympathetic paraganglioma
(
- Contribution to journal › Article
- 2020
-
Mark
ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Integrative discovery of treatments for high-risk neuroblastoma
(
- Contribution to journal › Article
-
Mark
Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma
(
- Contribution to journal › Article
-
Mark
Inflammatory macrophage derived TNFα downregulates estrogen receptor α via FOXO3a inactivation in human breast cancer cells
(
- Contribution to journal › Article
- 2019
-
Mark
ALK positively regulates MYCN activity through repression of HBP1 expression
(
- Contribution to journal › Article
- 2018
-
Mark
Promoter-associated proteins of EPAS1 identified by enChIP-MS – A putative role of HDX as a negative regulator
(
- Contribution to journal › Article
-
Mark
A Novel Topical PPAR 3 Agonist Induces PPAR 3 Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models
(
- Contribution to journal › Article
-
Mark
Patient-derived xenograft models reveal intratumor heterogeneity and temporal stability in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Refined control of cell stemness allowed animal evolution in the oxic realm
(
- Contribution to journal › Scientific review
-
Mark
Hypoxia and hypoxia-inducible factors in neuroblastoma
(
- Contribution to journal › Article
- 2017
-
Mark
Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum
(
- Contribution to journal › Article
-
Mark
No reason to reconsider HIF-2 as an oncogene in neuroblastoma and other cancer forms
2017) In Proceedings of the National Academy of Sciences of the United States of America 114(51). p.10856-10858(
- Contribution to journal › Letter
-
Mark
Hypoxia and Cancer Stem Cell Regulation
2017) p.101-126(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Hypoxia, pseudohypoxia and cellular differentiation
(
- Contribution to journal › Article
-
Mark
Myc-induced glutaminolysis bypasses HIF-driven glycolysis in hypoxic small cell lung carcinoma cells
(
- Contribution to journal › Article
- 2016
-
Mark
HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells.
(
- Contribution to journal › Article
-
Mark
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
(
- Contribution to journal › Scientific review
-
Mark
Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers
(
- Contribution to journal › Article
-
Mark
Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohort
(
- Contribution to journal › Article